Advocate Group LLC Medtronic PLC Transaction History

Advocate Group LLC

$531 Million
Q4 2024

A detailed history of Advocate Group LLC transactions in Medtronic PLC stock. As of the latest transaction made, Advocate Group LLC holds 106,776 shares of MDT stock, worth $9.44 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares

106,776

Previous 101,879 4.81%

Holding current value

$9.44 Million

Previous $9.17 Million 7.01%

% of portfolio

1.61%

Previous 1.67%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$79.61 - $92.24 $389,850 - $451,699	4,897 Added 4.81%	106,776 $8.53 Million
Q3 2024 Oct 08, 2024	BUY	$76.84 - $91.03 $351,619 - $416,553	4,576 Added 4.7%	101,879 $9.17 Million
Q2 2024 Jul 10, 2024	BUY	$78.71 - $87.02 $355,926 - $393,504	4,522 Added 4.87%	97,303 $7.66 Million
Q1 2024 Apr 25, 2024	BUY	$82.84 - $88.09 $407,738 - $433,578	4,922 Added 5.6%	92,781 $8.09 Million
Q4 2023 Jan 19, 2024	BUY	$69.43 - $83.43 $519,266 - $623,972	7,479 Added 9.3%	87,859 $7.24 Million
Q3 2023 Oct 17, 2023	BUY	$78.22 - $90.4 $439,752 - $508,228	5,622 Added 7.52%	80,380 $6.3 Million
Q2 2023 Jul 20, 2023	BUY	$79.47 - $91.38 $869,242 - $999,514	10,938 Added 17.14%	74,758 $6.59 Million
Q1 2023 Apr 19, 2023	BUY	$76.72 - $87.58 $926,163 - $1.06 Million	12,072 Added 23.33%	63,820 $5.15 Million
Q4 2022 Jan 18, 2023	SELL	$76.18 - $87.74 $422,722 - $486,869	-5,549 Reduced 9.68%	51,748 $0
Q3 2022 Oct 19, 2022	BUY	$80.75 - $95.31 $64,277 - $75,866	796 Added 1.41%	57,297 $4.63 Million
Q2 2022 Jul 27, 2022	BUY	$87.4 - $113.09 $4.94 Million - $6.39 Million	56,501 New	56,501 $5.07 Million

Others Institutions Holding MDT

# of Institutions

2,283

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advocate Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advocate Group LLC with notifications on news.

Account

Advocate Group LLC Medtronic PLC Transaction History